--Morgan Stanley Adjusts Price Target on LifeStance Health to $10 From $8, Maintains Overweight Rating

--Morgan Stanley Adjusts Price Target on LifeStance Health to $10 From $8, Maintains Overweight Rating

MT Newswires · 05/11/2023 04:54

Please log in to view news